In a prior report, we showed that mTOR and HIF-1α blockade are particularly important mediators of the direct activity of HIF-1α inhibition in GBM cells [21], but the most relevant downstream mediators may vary across different GBMs. The gene discussed is HIF1A; the disease is glioblastoma.